Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 2,716.95
+2.65 (0.10%)
At close: Jan 22, 2026
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 337.15 billion as of January 23, 2026. Its market cap has decreased by -6.06% in one year.
Market Cap
337.15B
Enterprise Value
330.21B
Revenue
49.73B
Ranking
n/a
PE Ratio
34.63
Stock Price
2,716.95
Market Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 337.15B, an increase of 59,488.13%. That is a compound annual growth rate of 30.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 339.40B | -1.85% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lupin | 989.47B |
| Dr. Reddy's Laboratories | 971.48B |
| Abbott India | 578.31B |
| GlaxoSmithKline Pharmaceuticals | 384.52B |
| J. B. Chemicals & Pharmaceuticals | 294.79B |
| AstraZeneca Pharma India | 206.24B |
| Jubilant Pharmova | 150.52B |
| Caplin Point Laboratories | 137.79B |